Survey Shows MS Impacts All Aspects of Life & Remembering My First MS Symptom
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads an article about how MS affects all aspects of life, from physical and mental health to relationships and hobbies, accordi...
13 Touko 202211min
PoNS Device for MS Gait Problems Available in US & MSer Bed-bound for 2 Years Can Now Walk
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge reads an article about the portable neuromodulation stimulator (PoNS) device that was approved by the FDA last year to help treat...
11 Touko 20229min
NfL Levels Help Predict Relapsing MS Progression & Bone Marrow Infusions and Other MS News
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how blood levels of neurofilament light chain (NfL) helped predict disease progression in multiple sc...
9 Touko 202213min
Biomarker Test Granted Breakthrough Device Status & Intermittent Catheterization With a Wheelchair
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how a blood test for the multiple sclerosis biomarker, neurofilament light chain, has been granted breakthrough device...
6 Touko 20228min
Trial of Metformin-Clemastine Combo Enrolls First Patient & The High Cost of Living With MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how a trial will test an antihistamine in combination with the diabetes medicine metformin as a way to repair the myel...
4 Touko 20229min
Active PMS Patients Safely Underwent a Repeat Bone Marrow Infusion & Plasmapheresis Experience
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how four active progressive MS patients safely underwent a second harvesting and infusion of bone marrow cells in a sa...
2 Touko 202210min
1st RRMS Patient Dosed in Trial of Immunotherapy & MS News That Caught Ed Tobias' Attention
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how a Phase 1/2 clinical trial has begun dosing with IMCY-0141, Imcyse’s targeted immunotherapy to sl...
29 Huhti 202210min
Jenn Powell Talks to Neurologist Dr. Brandon Beaber
Dr. Brandon Beaber is a board-certified neurologist with subspecialty training in multiple sclerosis and other immunological diseases of the nervous system. Dr. Beaber is also the author of Resilience...
28 Huhti 202239min
